MiMedx Group, Inc. (MDXG)
4.565
+0.14
(+3.05%)
USD |
NASDAQ |
Sep 04, 16:00
4.565
0.00 (0.00%)
After-Hours: 19:51
MiMedx Group Cash and Short Term Investments (Annual) : 166.12M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 166.12M |
| December 31, 2024 | 104.42M |
| December 31, 2023 | 82.00M |
| December 31, 2022 | 65.95M |
| December 31, 2021 | 87.08M |
| December 31, 2020 | 95.81M |
| December 31, 2019 | 69.07M |
| December 31, 2018 | 45.12M |
| December 31, 2017 | 27.48M |
| December 31, 2016 | 34.39M |
| Date | Value |
|---|---|
| December 31, 2015 | 31.49M |
| December 31, 2014 | 52.33M |
| December 31, 2013 | 44.08M |
| December 31, 2012 | 6.754M |
| December 31, 2011 | 4.112M |
| December 31, 2010 | 1.341M |
| March 31, 2010 | |
| March 31, 2009 | 0.0348M |
| March 31, 2008 | 6.750M |
| March 31, 2007 | 10.63M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Anika Therapeutics, Inc. | 57.48M |
| Perspective Therapeutics, Inc. | 144.74M |
| ABVC BioPharma, Inc. | 1.391M |
| Enovis Corp. | 36.39M |
| Edwards Lifesciences Corp. | 4.227B |